Gateway 2012: Allegheny Bradford Corporation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Allegheny Bradford Corporation


Allegheny Bradford Corporation
www.alleghenybradford.com
11 Lincoln Drive
Lewis Run, PA 16738
William Waytenick - General Sales Manager sales@alleghenybradford.com, wwaytenick@alleghenybradford.com

Description of Company:

Manufacturers and fabricators of the highest quality heat transfer, filter housing, tanks, pressure vessels, process systems and custom fabrication in stainless steel and high nickel alloys for the pharmaceutical and biotechnical industries for end users and OEM's.

The Allegheny Bradford Corporation started in 1962 manufacturing stainless steel equipment. Our 50 years of experience has taught us to put our customer’s needs first. Our reputation of precision engineered equipment sets the standard for quality and performance. Unsurpassed documentation set ABC apart from its competitors and is the best in the industry. We are dedicated to our customers and are with them every step of the way.

Booth Invitation:

Allegheny Bradford Corporation is pleased to announce that we are exhibiting at INTERPHEX 2012. The INTERPHEX show is May 1–3 at Jacob K. Javitz Convention Center, New York, NY. Please stop by and visit us at booth 2645 .

Automated Sampling Systems – Our sampling/POU systems can support manual to fully automated Sampling, CIP and SIP of the fluid lines.

Stainless Steel Tanks – All stainless steel pressure tanks and vessels are custom made.

PDFs & Links:
ABC Shell & Tube Heat Exchangers
ABC Filter Housings
Stainless Steel Tanks
Modular Process Systems
How2Media announces that Allegheny Bradford Corporation will be a part of its "World's Greatest!" series

 

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here